elysium healthcare no. 2 limited
elysium healthcare no. 2 limited Company Information
Company Number
06244878
Next Accounts
13 days late
Shareholders
elysium healthcare holdings 3 limited
Group Structure
View All
Industry
Hospital activities
Registered Address
2 imperial place, imperial place, maxwell road, borehamwood, WD6 1JN
Website
www.elysiumhealthcare.co.ukelysium healthcare no. 2 limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE NO. 2 LIMITED at £231.4m based on a Turnover of £207.4m and 1.12x industry multiple (adjusted for size and gross margin).
elysium healthcare no. 2 limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE NO. 2 LIMITED at £316.7m based on an EBITDA of £41m and a 7.73x industry multiple (adjusted for size and gross margin).
elysium healthcare no. 2 limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE NO. 2 LIMITED at £185.5m based on Net Assets of £73.4m and 2.53x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elysium Healthcare No. 2 Limited Overview
Elysium Healthcare No. 2 Limited is a live company located in borehamwood, WD6 1JN with a Companies House number of 06244878. It operates in the hospital activities sector, SIC Code 86101. Founded in May 2007, it's largest shareholder is elysium healthcare holdings 3 limited with a 100% stake. Elysium Healthcare No. 2 Limited is a established, mega sized company, Pomanda has estimated its turnover at £207.4m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Elysium Healthcare No. 2 Limited Health Check
Pomanda's financial health check has awarded Elysium Healthcare No. 2 Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
3 Weak
Size
annual sales of £207.4m, make it larger than the average company (£4m)
£207.4m - Elysium Healthcare No. 2 Limited
£4m - Industry AVG
Growth
3 year (CAGR) sales growth of 26%, show it is growing at a faster rate (7.4%)
26% - Elysium Healthcare No. 2 Limited
7.4% - Industry AVG
Production
with a gross margin of 30.1%, this company has a comparable cost of product (35.4%)
30.1% - Elysium Healthcare No. 2 Limited
35.4% - Industry AVG
Profitability
an operating margin of 10.1% make it as profitable than the average company (9.7%)
10.1% - Elysium Healthcare No. 2 Limited
9.7% - Industry AVG
Employees
with 2397 employees, this is above the industry average (50)
2397 - Elysium Healthcare No. 2 Limited
50 - Industry AVG
Pay Structure
on an average salary of £47.4k, the company has a higher pay structure (£32.5k)
£47.4k - Elysium Healthcare No. 2 Limited
£32.5k - Industry AVG
Efficiency
resulting in sales per employee of £86.5k, this is equally as efficient (£75.8k)
£86.5k - Elysium Healthcare No. 2 Limited
£75.8k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (26 days)
0 days - Elysium Healthcare No. 2 Limited
26 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare No. 2 Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (11 days)
0 days - Elysium Healthcare No. 2 Limited
11 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (30 weeks)
0 weeks - Elysium Healthcare No. 2 Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 69%, this is a higher level of debt than the average (50.8%)
69% - Elysium Healthcare No. 2 Limited
50.8% - Industry AVG
ELYSIUM HEALTHCARE NO. 2 LIMITED financials
Elysium Healthcare No. 2 Limited's latest turnover from June 2023 is £207.4 million and the company has net assets of £73.4 million. According to their latest financial statements, Elysium Healthcare No. 2 Limited has 2,397 employees and maintains cash reserves of £102 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 207,366,000 | 113,857,000 | 102,879,000 | 88,916,000 | 79,207,000 | 79,325,000 | 65,266,000 | 49,346,000 | 46,329,000 | 42,090,000 | 40,640,000 | 44,279,000 | 47,803,000 | 46,266,000 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | 145,026,000 | 75,537,000 | 69,006,000 | 59,579,000 | 53,086,000 | 59,096,000 | 56,192,000 | 41,816,000 | 39,019,000 | 37,367,000 | 36,853,000 | 38,654,000 | 39,169,000 | 36,989,000 |
| Gross Profit | 62,340,000 | 38,320,000 | 33,873,000 | 29,337,000 | 26,121,000 | 20,229,000 | 9,074,000 | 7,530,000 | 7,310,000 | 4,723,000 | 3,787,000 | 5,625,000 | 8,634,000 | 9,277,000 |
| Admin Expenses | 41,504,000 | 20,670,000 | 21,607,000 | 19,029,000 | 17,779,000 | 10,666,000 | 1,547,000 | 2,190,000 | 2,178,000 | 1,547,000 | 1,368,000 | 2,506,000 | 2,260,000 | 3,168,000 |
| Operating Profit | 20,836,000 | 17,650,000 | 12,266,000 | 10,308,000 | 8,342,000 | 9,563,000 | 7,527,000 | 5,340,000 | 5,132,000 | 3,176,000 | 2,419,000 | 3,119,000 | 6,374,000 | 6,109,000 |
| Interest Payable | 3,499,000 | 2,179,000 | 2,061,000 | 1,761,000 | 1,740,000 | 1,771,000 | 7,659,000 | 10,044,000 | 10,122,000 | 10,241,000 | 10,487,000 | 10,511,000 | 9,075,000 | 10,916,000 |
| Interest Receivable | 25,000 | 1,997,000 | 99,000 | |||||||||||
| Pre-Tax Profit | 17,337,000 | 15,471,000 | 10,230,000 | 8,547,000 | 6,602,000 | 9,784,000 | 15,308,000 | -4,704,000 | -4,990,000 | -7,065,000 | -8,068,000 | -7,392,000 | -2,693,000 | -4,796,000 |
| Tax | 80,000 | -6,643,000 | 2,374,000 | -3,498,000 | -994,000 | 620,000 | 227,000 | 2,765,000 | 1,090,000 | 4,302,000 | 217,000 | 155,000 | -1,027,000 | 469,000 |
| Profit After Tax | 17,417,000 | 8,828,000 | 12,604,000 | 5,049,000 | 5,608,000 | 10,404,000 | 15,535,000 | -1,939,000 | -3,900,000 | -2,763,000 | -7,851,000 | -7,237,000 | -3,720,000 | -4,327,000 |
| Dividends Paid | ||||||||||||||
| Retained Profit | 17,417,000 | 8,828,000 | 12,604,000 | 5,049,000 | 5,608,000 | 10,404,000 | 15,535,000 | -1,939,000 | -3,900,000 | -2,763,000 | -7,851,000 | -7,237,000 | -3,720,000 | -4,327,000 |
| Employee Costs | 113,613,000 | 61,007,000 | 56,379,000 | 46,785,000 | 42,421,000 | 40,673,000 | 36,299,000 | 26,666,000 | 25,571,000 | 24,185,000 | 22,669,000 | 23,816,000 | 22,070,000 | 21,305,000 |
| Number Of Employees | 2,397 | 2,112 | 1,505 | 1,993 | 1,625 | 1,356 | 1,328 | 966 | 857 | 805 | 928 | 934 | 847 | 808 |
| EBITDA* | 40,990,000 | 26,394,000 | 21,085,000 | 18,951,000 | 19,349,000 | 17,638,000 | 13,700,000 | 11,813,000 | 11,356,000 | 10,866,000 | 10,043,000 | 10,672,000 | 13,854,000 | 13,404,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 147,083,000 | 146,163,000 | 149,405,000 | 146,833,000 | 147,270,000 | 148,999,000 | 98,591,000 | 97,784,000 | 102,178,000 | 106,351,000 | 111,597,000 | 114,971,000 | 119,326,000 | |
| Intangible Assets | 8,661,000 | 10,859,000 | 12,323,000 | 13,787,000 | 15,251,000 | 16,715,000 | 18,179,000 | 21,108,000 | 29,289,000 | 29,289,000 | 21,108,000 | 22,572,000 | 24,037,000 | 25,501,000 |
| Investments & Other | 150,920,000 | 1,000 | 1,000 | |||||||||||
| Debtors (Due After 1 year) | 1,997,000 | 72,750,000 | ||||||||||||
| Total Fixed Assets | 159,581,000 | 157,942,000 | 158,486,000 | 163,192,000 | 162,085,000 | 165,983,000 | 239,928,000 | 119,699,000 | 127,073,000 | 131,467,000 | 127,459,000 | 134,169,000 | 139,008,000 | 144,827,000 |
| Stock & work in progress | 268,000 | 180,000 | 172,000 | 110,000 | 82,000 | 77,000 | ||||||||
| Trade Debtors | 58,000 | 488,000 | 7,279,000 | 3,845,000 | 4,565,000 | 7,248,000 | 7,516,000 | 4,229,000 | 3,793,000 | 3,174,000 | 2,315,000 | 2,240,000 | 4,034,000 | 5,544,000 |
| Group Debtors | 70,017,000 | 53,972,000 | 33,935,000 | 11,456,000 | 811,000 | 12,759,000 | 10,420,000 | |||||||
| Misc Debtors | 6,241,000 | 4,684,000 | 3,381,000 | 3,739,000 | 2,710,000 | 3,725,000 | 1,038,000 | 40,000 | 558,000 | 976,000 | 1,032,000 | 684,000 | 598,000 | 604,000 |
| Cash | 102,000 | 2,295,000 | 1,682,000 | 782,000 | 254,000 | 2,316,000 | 4,392,000 | 32,000 | 27,000 | 121,000 | 18,000 | 2,697,000 | 2,773,000 | 1,323,000 |
| misc current assets | ||||||||||||||
| total current assets | 76,686,000 | 61,619,000 | 46,449,000 | 19,932,000 | 7,611,000 | 13,366,000 | 12,946,000 | 4,301,000 | 4,378,000 | 4,271,000 | 3,365,000 | 6,432,000 | 20,164,000 | 17,891,000 |
| total assets | 236,267,000 | 219,561,000 | 204,935,000 | 183,124,000 | 169,696,000 | 179,349,000 | 252,874,000 | 124,000,000 | 131,451,000 | 135,738,000 | 130,824,000 | 140,601,000 | 159,172,000 | 162,718,000 |
| Bank overdraft | ||||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | 1,188,000 | 1,893,000 | 832,000 | 434,000 | 604,000 | |||||||||
| Group/Directors Accounts | 78,770,000 | 78,770,000 | 78,770,000 | 78,770,000 | 71,723,000 | 86,771,000 | 162,469,000 | 14,963,000 | 7,900,000 | 5,753,000 | 6,638,000 | 15,792,000 | ||
| other short term finances | ||||||||||||||
| hp & lease commitments | 2,270,000 | 2,162,000 | 2,252,000 | 1,865,000 | 1,727,000 | 1,600,000 | 1,701,000 | 10,752,000 | 10,488,000 | 10,243,000 | 10,003,000 | 9,760,000 | 9,519,000 | 31,000 |
| other current liabilities | 3,834,000 | 4,923,000 | 3,922,000 | 5,515,000 | 4,637,000 | 3,456,000 | 6,984,000 | 2,859,000 | 2,764,000 | 3,172,000 | 4,120,000 | 5,129,000 | 8,958,000 | 8,628,000 |
| total current liabilities | 84,874,000 | 85,855,000 | 84,944,000 | 87,338,000 | 79,980,000 | 92,659,000 | 171,154,000 | 28,574,000 | 21,152,000 | 19,168,000 | 14,123,000 | 14,889,000 | 25,549,000 | 25,055,000 |
| loans | 127,000 | 4,622,000 | 38,845,000 | 38,845,000 | 38,845,000 | 38,664,000 | 38,845,000 | 38,845,000 | 38,845,000 | |||||
| hp & lease commitments | 57,909,000 | 58,054,000 | 57,992,000 | 47,775,000 | 46,313,000 | 47,907,000 | 47,907,000 | 110,329,000 | 112,275,000 | 113,829,000 | 115,076,000 | 116,055,000 | 116,729,000 | 117,049,000 |
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | ||||||||||||||
| provisions | 20,120,000 | 19,705,000 | 14,880,000 | 13,496,000 | 13,937,000 | 14,798,000 | 15,737,000 | 14,390,000 | 17,197,000 | 18,014,000 | ||||
| total long term liabilities | 78,029,000 | 77,759,000 | 72,872,000 | 61,271,000 | 60,250,000 | 62,832,000 | 68,266,000 | 163,564,000 | 168,317,000 | 170,688,000 | 153,740,000 | 154,900,000 | 155,574,000 | 155,894,000 |
| total liabilities | 162,903,000 | 163,614,000 | 157,816,000 | 148,609,000 | 140,230,000 | 155,491,000 | 239,420,000 | 192,138,000 | 189,469,000 | 189,856,000 | 167,863,000 | 169,789,000 | 181,123,000 | 180,949,000 |
| net assets | 73,364,000 | 55,947,000 | 47,119,000 | 34,515,000 | 29,466,000 | 23,858,000 | 13,454,000 | -68,138,000 | -58,018,000 | -54,118,000 | -37,039,000 | -29,188,000 | -21,951,000 | -18,231,000 |
| total shareholders funds | 73,364,000 | 55,947,000 | 47,119,000 | 34,515,000 | 29,466,000 | 23,858,000 | 13,454,000 | -68,138,000 | -58,018,000 | -54,118,000 | -37,039,000 | -29,188,000 | -21,951,000 | -18,231,000 |
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 20,836,000 | 17,650,000 | 12,266,000 | 10,308,000 | 8,342,000 | 9,563,000 | 7,527,000 | 5,340,000 | 5,132,000 | 3,176,000 | 2,419,000 | 3,119,000 | 6,374,000 | 6,109,000 |
| Depreciation | 17,956,000 | 7,280,000 | 7,355,000 | 7,179,000 | 9,543,000 | 6,611,000 | 6,173,000 | 6,473,000 | 6,224,000 | 6,226,000 | 6,160,000 | 6,088,000 | 6,016,000 | 5,831,000 |
| Amortisation | 2,198,000 | 1,464,000 | 1,464,000 | 1,464,000 | 1,464,000 | 1,464,000 | 1,464,000 | 1,464,000 | 1,465,000 | 1,464,000 | 1,464,000 | |||
| Tax | 80,000 | -6,643,000 | 2,374,000 | -3,498,000 | -994,000 | 620,000 | 227,000 | 2,765,000 | 1,090,000 | 4,302,000 | 217,000 | 155,000 | -1,027,000 | 469,000 |
| Stock | 268,000 | 8,000 | 62,000 | 28,000 | 5,000 | 77,000 | ||||||||
| Debtors | 76,316,000 | 14,549,000 | 25,555,000 | 11,765,000 | -5,695,000 | -68,334,000 | 77,035,000 | -82,000 | 201,000 | 803,000 | -388,000 | -13,656,000 | 823,000 | 16,568,000 |
| Creditors | -1,188,000 | -705,000 | 1,061,000 | 832,000 | -434,000 | -170,000 | 604,000 | |||||||
| Accruals and Deferred Income | 3,834,000 | 1,001,000 | -1,593,000 | 878,000 | 1,181,000 | -3,528,000 | 4,125,000 | 95,000 | -408,000 | -948,000 | -1,009,000 | -3,829,000 | 330,000 | 8,628,000 |
| Deferred Taxes & Provisions | 20,120,000 | 4,825,000 | 1,384,000 | -441,000 | -861,000 | -939,000 | 1,347,000 | -2,807,000 | -817,000 | 18,014,000 | ||||
| Cash flow from operations | -11,560,000 | 11,020,000 | -3,555,000 | 3,392,000 | 25,426,000 | 82,880,000 | -57,636,000 | 11,948,000 | 11,020,000 | 31,431,000 | 9,639,000 | 20,220,000 | 12,164,000 | 6,537,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 150,920,000 | -1,000 | 1,000 | |||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | 78,770,000 | 7,047,000 | -15,048,000 | -75,698,000 | 147,506,000 | 7,063,000 | 2,147,000 | 5,753,000 | -6,638,000 | -9,154,000 | 15,792,000 | |||
| Other Short Term Loans | ||||||||||||||
| Long term loans | -127,000 | -4,495,000 | -34,223,000 | 181,000 | -181,000 | 38,845,000 | ||||||||
| Hire Purchase and Lease Commitments | 60,179,000 | -28,000 | 10,604,000 | 1,600,000 | -1,467,000 | -101,000 | -71,473,000 | -1,682,000 | -1,309,000 | -1,007,000 | -736,000 | -433,000 | 9,168,000 | 117,080,000 |
| other long term liabilities | ||||||||||||||
| share issue | ||||||||||||||
| interest | -3,499,000 | -2,179,000 | -2,036,000 | -1,761,000 | -1,740,000 | 226,000 | -7,560,000 | -10,044,000 | -10,122,000 | -10,241,000 | -10,487,000 | -10,511,000 | -9,075,000 | -10,916,000 |
| cash flow from financing | 191,397,000 | -2,207,000 | 8,568,000 | 6,886,000 | -18,382,000 | -80,068,000 | 100,307,000 | -12,844,000 | -9,284,000 | -19,630,000 | -11,404,000 | -17,582,000 | -9,061,000 | 146,897,000 |
| cash and cash equivalents | ||||||||||||||
| cash | 102,000 | 613,000 | 900,000 | 528,000 | -2,062,000 | -2,076,000 | 4,360,000 | 5,000 | -94,000 | 103,000 | -2,679,000 | -76,000 | 1,450,000 | 1,323,000 |
| overdraft | ||||||||||||||
| change in cash | 102,000 | 613,000 | 900,000 | 528,000 | -2,062,000 | -2,076,000 | 4,360,000 | 5,000 | -94,000 | 103,000 | -2,679,000 | -76,000 | 1,450,000 | 1,323,000 |
elysium healthcare no. 2 limited Credit Report and Business Information
Elysium Healthcare No. 2 Limited Competitor Analysis
Perform a competitor analysis for elysium healthcare no. 2 limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mega companies, companies in WD6 area or any other competitors across 12 key performance metrics.
elysium healthcare no. 2 limited Ownership
ELYSIUM HEALTHCARE NO. 2 LIMITED group structure
Elysium Healthcare No. 2 Limited has 1 subsidiary company.
Ultimate parent company
P HEALTH SARL
#0102578
2 parents
ELYSIUM HEALTHCARE NO. 2 LIMITED
06244878
1 subsidiary
elysium healthcare no. 2 limited directors
Elysium Healthcare No. 2 Limited currently has 4 directors. The longest serving directors include Dr Quazi Haque (Dec 2016) and Mrs Kathryn Murphy (Sep 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Quazi Haque | 56 years | Dec 2016 | - | Director | |
| Mrs Kathryn Murphy | United Kingdom | 62 years | Sep 2020 | - | Director |
| Mr Colin McCready | United Kingdom | 49 years | Jul 2023 | - | Director |
| Miss Sheetal Shah | United Kingdom | 46 years | Oct 2024 | - | Director |
P&L
June 2023turnover
207.4m
0%
operating profit
20.8m
0%
gross margin
30.1%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
73.4m
0%
total assets
236.3m
0%
cash
102k
0%
net assets
Total assets minus all liabilities
elysium healthcare no. 2 limited company details
company number
06244878
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
May 2007
age
18
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
June 2023
previous names
priory secure services limited (December 2016)
priory s s limited (June 2007)
accountant
-
auditor
-
address
2 imperial place, imperial place, maxwell road, borehamwood, WD6 1JN
Bank
-
Legal Advisor
-
elysium healthcare no. 2 limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to elysium healthcare no. 2 limited. Currently there are 0 open charges and 10 have been satisfied in the past.
elysium healthcare no. 2 limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELYSIUM HEALTHCARE NO. 2 LIMITED. This can take several minutes, an email will notify you when this has completed.
elysium healthcare no. 2 limited Companies House Filings - See Documents
| date | description | view/download |
|---|
